Abstract
Coronary artery disease (CAD) can be obstructive or nonobstructive. Patients with nonobstructive and stable angina pectoris are usually women. Nonobstructive CAD is caused by endothelial dysfunction at the microvascular level, such as cardiac syndrome X and coronary slow flow syndrome. Even if coronary anatomy is nonobstructive, the presence of myocardial ischemia is a major determinant for the exercise program. CAD is a chronic inflammatory disease, and the progression of the disease can lead to a rapid change in the functional capacity of CAD patients. Exercise training is a major component of cardiac rehabilitation and reduces cardiovascular mortality, morbidity, and rehospitalization as well as improves psychological stress and controls risk factors of CAD, such as diabetes mellitus, hypertension, and obesity. It is possible that the quality of life of patients with CAD can be improved by using appropriate exercise therapy. However, the exercise programs among CAD patients are highly underutilized. This chapter will summarize the research progress of exercise in the prevention and treatment of CAD as well as how to create safe exercise programs and the importance of exercise for patients with CAD. In addition, exercise training has fundamental beneficial effects on ischemic and nonischemic heart failure.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
1 Background
William Heberden, who first described the angina pectoris, noted that “If we give a task of sawing to a patient for half an hour every day, we may cure him.” Hippocrates declared 2500 years ago, “the right amount of exercise, not too little and not too much, is the safest way to health.” Currently, all CAD patients should be encouraged to regular exercise for long life even though they are symptomatic.
Age, hyperlipidemia, hypertension, cigarette use, diabetes mellitus, and sedentary activity are risk factors for the development of CAD. Some of these factors can be modified such as diet, smoking, and still life activity [1]. Sedentary behaviors increase the risk of cardiovascular mortality [2]. CAD has been reported as a cause of death in one in five people and its annual cost is more than $160 billion [3]. CAD is likely to cause death, especially over the age of 35 [4]. Acute myocardial infarction (AMI), unstable angina pectoris, cardiac arrest, and heart failure may occur as a result of CAD [5, 6]. Atherosclerosis not only relates to be a cholesterol storage disease characterized by the collection of cholesterol and thrombotic debris in the artery [7], but it also associates with chronic inflammation and endothelial dysfunction [8]. Physical activity levels decrease systemic markers of inflammation, thrombosis, and endothelial dysfunction [9,10,11]. Genetic inheritance and lifestyle are important determining factors for CAD development [12, 13]. Therefore, physical activity has a key role in preventing CAD development via decreasing endothelial dysfunction and inflammation. Avoiding a sedentary lifestyle during adulthood not only prevents cardiovascular disease independently of other risk factors, but it also substantially expands the total life expectancy and the cardiovascular disease-free life expectancy for both sexes. This effect is seen at moderate levels of physical activity, and the gains in cardiovascular disease-free life expectancy are highly increased at higher activity levels [14]. Franco et al. [14] also found that life expectancy for sedentary people at age 50 years was found to be 1.5 years shorter than for people engaging in moderate daily physical activity and more than 3.5 years shorter than for people with high physical activity levels. These differences were similar for both sexes’ CAD severity, and the number of coronary artery vessels’ involvement, the degree of myocardial ischemia, the severity of angina, left ventricle function, and general health condition are important determinants of life expectancy and quality in patients with CAD [15]. In the treatment of CAD, many methods are used together, such as physical activity, weight control, smoking cessation, blood pressure control, control of lipid levels in the blood, diabetes control, and drug use (acetyl salicylic acid, beta-blockers, nitrates, etc.) [15]. It is also recommended that patients with CAD receive annual influenza vaccines [16]. Regular exercise is not only beneficial for both CAD prevention and treatment, but it also helps in the modification of CHD risk factors such as diabetes, hypertension, and hyperlipidemia [17,18,19,20]. Increased myocardial and peripheral artery perfusion and higher exercise capacity are related to lower mortality and morbidity of CAD [21, 22]. However, the basic mechanism of these positive effects is not fully understood. It is stated that this situation may be due to the improvement of endothelial functions and decrease of inflammation [23,24,25].
1.1 Exercise Definition
While dynamic exercise increases heart rate, static exercise increases blood pressure. For example, running is a dynamic exercise, and weight lifting is a static exercise. However, most of the sports include both dynamic and static exercise (Table 11.1) [26]. The effect of dynamic exercise is evaluated by its effect on both maximal oxygen consumption and the percentage of cardiac output. The effect of static exercise is assessed by the increase in blood pressure and its effect on muscle strength. According to dynamic or static exercises’ features, the classification of sports was categorized by the American Heart Association and American College of Cardiology (Table 11.2) [27].
2 Dynamic (Isotonic-Aerobic) and Static (Isometric-Resistance) Exercise and Cardiovascular Response
The exercise capacity is often consistent with the CAD severity. However, CAD patients may respond to dynamic exercise in various ways, such as myocardial ischemia, irreversible myocardial necrosis, and conduction abnormalities or normal [28,29,30]. Because the difference in coronary arteriovenous oxygen is unchanged, reduced exercise tolerance is often attributed to the decrease in heart rate and stroke volume. The arterial blood pressure response may be increased, normal, or decreased. A decrease in blood pressure is critical for patients with impaired left ventricular function due to myocardial ischemia. Myocardial lesions may cause left ventricular dysfunction. When left ventricular dysfunction progresses, the increase in heart rate does not fully meet the decrease in stroke volume. If more than 50% of the coronary artery diameter is affected by atherosclerosis, coronary insufficiency is encountered during exercise. The increased oxygen requirement of the peripheral tissue can be supplied by increasing the arteriovenous oxygen difference. Therefore, the absence of symptoms associated with exercise does not mean that there is no atherosclerosis in the coronary arteries [31]. Because the CAD severity increases, the probability of the coronary insufficiency triggered by exercise increases. The number of coronary vessels involved is also important, and as the number increases, the exercise capacity also decreases. Lesion complexity may not be directly proportional with the symptoms. The patient with a single coronary artery stenosis may be more symptomatic during a mild exercise, while a patient with two to three coronary vessel involvement may be asymptomatic at higher work capacity due to having good coronary collaterals. For this reason, functional classifications may be more guiding for the evaluation of patients’ exercise capacity [31, 32]. The possibility of ischemia is higher in patients with CAD as the oxygen requirement of myocardium increases during exercise. This happens due to the higher end-diastolic volume and lower left ventricular ejection fraction caused by ischemia. The ST changes in ECG can be seen. Stress nuclear imaging or echocardiography should be performed for the evaluation of ischemia degree. Ischemia usually occurs on a specific exercise threshold in patients with CAD. This threshold can be assessed by the double product response calculated by multiplying the heart rate and systolic blood pressure. Dynamic upper extremity exercises may be useful to increase exercise threshold where ischemia begins [33]. In the supine position exercise, the threshold level decreases due to the increase in the end-diastolic volume of both ventricles. Because static exercises increase diastolic blood pressure and coronary flow in diastole, static exercise may increase threshold of ischemia [34, 35]. Therefore, CAD patients should do both dynamic and static exercises together.
3 Exercise and Inflammatory Response
Coronary artery atherosclerosis has different stages of the development. These stages include circulating plasma oxidized low-density lipoprotein cholesterol (LDL-C) entering subintimal area in the coronary vessel; upregulation of some adhesion molecules, such as vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), E-selectin, and P-selectin; upregulation of some chemotactic molecules, such as monocyte chemoattractant protein-1 (MCP-1); upregulation of metalloproteinases; influx of coagulation proteins; monocyte and T-lymphocyte movement to the arterial vessel wall; expression of some chemokines and cytokines, such as MCP-1, interferon gamma, tumor necrosis factor alpha (TNF-α), and interleukin-6 (IL-6); migration of smooth muscle cells from media into the intima; vascular endothelial growth factor (VEGF) production; and fibrous cap formation, subsequently [36, 37]. Palmefors et al. [38] have shown in their meta-analysis that physical activity decreases TNF-α, IL-6, VCAM-1, ICAM-1, C-reactive protein (CRP), and VEGF levels in patients with atherosclerosis. Some studies have presented the findings of exercise positive effects on coronary artery atherosclerosis [39, 40].
4 Exercise and Brain Natriuretic Peptides
Recently, there is growing interest in the evaluation of the relationship between exercise and ischemia. Plasma levels of brain natriuretic peptides (BNP) significantly increased during acute myocardial ischemia associated with dynamic exercise [41]. BNP levels can show the degree of left ventricular systolic dysfunction [42]. It was reported that BNP is a strong predictor of mortality in acute coronary syndromes and may be a strong prognostic marker in chronic coronary syndromes [43]. BNP show a positive correlation with peak exercise and anaerobic threshold in CAD patients, and it can improve the diagnostic accuracy of exercise testing [44, 45].
5 Benefits of Exercise Training and Secondary CAD Prevention
Regular physical activity improves exercise capacity [46]; increases estimated metabolic equivalents (+35%) [47, 48], peak oxygen consumption (+15%) [49], and peak anaerobic threshold (+11%) [49, 50]; decreases total cholesterol (−5%) [51, 52], triglycerides (−15%) [52], and LDL-C (−2%) [51, 52]; increases high-density lipoprotein cholesterol (+6%) [53]; reduces insulin resistance and body mass index (−1.5%) [54, 55], metabolic syndrome (−37%) [56, 57], and high-sensitivity CRP (−40%) [57, 58]; decreases anxiety [59], hostility [59], somatization [59], and mental depression [60]; improves autonomic tone (increased heart rate recovery and variability) [61]; reduces resting heart rate [61]; improves blood rheology [38], and reduces hospitalization costs, morbidity, and mortality [62,63,64].
6 Exercise Training and Cardiovascular Response
Higher intensities of exercise may not be sustainable for longer periods. Therefore, interval training was proposed by physicians [65]. Traditional training methods include continuous training (30–60 min) at moderate intensity (40–80% of VO2 peak) (aerobic continuous training), leading to gains in VO2 peak of approximately 20% after 12 weeks of three times-weekly exercise sessions [66, 67]. Even within the high-intensity training zone, exercise intensity was an important determinant for improving VO2 peak in patients with CAD [68]. An increase of 1 mL/kg/min in exercise capacity yields an almost 15% increase in survival [69]. Villelabeitia et al. [70] have shown that high-intensity interval training (HIIT) results in a significantly greater increase in VO2 peak compared with moderate continuous training (MCT). The aerobic threshold increased by 21% in HIIT and 14% in moderate continuous training (MCT). HIIT consists of a repeating series of high-intensity (peak interval) exercises, alternating with periods of low-intensity exercise (recovery interval). MCT program consists of aerobic dynamic exercise and aims at 60–80% of VO2 peak. The studies on the benefits of MCT exercise have shown a significant improvement in terms of VO2 peak [49].
7 Exercise Programs in Primary and Secondary Prevention of CAD
Both dynamic (aerobic) and static (resistance) exercise mode are proposed for all CAD patients. Dynamic exercise should be at least 20–30 min (preferably 30–45 min), and static exercise should be 10–15 repetitions, 1–3 sets of 8–10 different exercises for all extremities. The frequency of dynamic exercise should include most days (at least 4–5 days/week and preferably 6–7 days/week). The frequency of static exercise should include two to three sessions weekly (nonconsecutive days). The intensity of dynamic exercise should be close to anaerobic threshold: 50–75% peak VO2, 65–85% of maximal heart rate or 60–80% of heart rate reserve, and 10–15 beats/min below the level of ischemia. Borg Rating of Perceived Exertion (BORG) scale can be used for this purpose. The recommended intensity of walking is a perceived exertion of 11–13 on the BORG scale. The intensity of static exercise should be moderate intensity [46, 71,72,73]. A CAD patient may have some symptoms during exercise, such as muscle overload, fatigue, muscular pain, dyspnea without oxygen desaturation, dyspnea with desaturation <94%, muscle injury, vasovagal conditions, ischemia, ventricular arrhythmia, or hypertensive emergencies. In these circumstances, exercise program should be reconsidered by the patient’s physician.
7.1 Telehealth Interventions in CAD Exercise Program
Huang et al. [74] have shown that telehealth (such as the telephone, computer, Internet, and videoconferencing) interventions have a beneficial effect on risk factor reduction and secondary prevention for CAD patients. Telehealth intervention-delivered cardiac rehabilitation does not have significantly inferior outcomes compared to center-based supervised program in low to moderate risk CAD patients. Telehealth models may be helpful for the secondary prevention, especially among CAD patient who do not access cardiac rehabilitation [75].
7.2 Exercise-Based Cardiac Rehabilitation After AMI
Patients presenting with AMI should be encouraged for early ambulation (day 1). After early ambulation, the intensity of the exercise program should be quite low. Walking or mild level of gymnastic can be used for this purpose. If extensive myocardial damage, heart failure, hypotension, or arrhythmias exists initially, ambulation should be deterred for clinical stabilization. All AMI patients should be included in the exercise program after AMI [64]. A standard exercise-based cardiac rehabilitation must take account of patients’ age, pre-infarction level of activity, and physical limitations. Exercise training, risk factor modification, education and stress management, and psychological support should be major determinants of the cardiac rehabilitation [76]. The best approach is to perform a low-level treadmill test after discharging and decide on the appropriate exercise program. The type, duration, frequency, and severity of the planned exercise should be prescribed for all CAD patients. Static or resistance exercise types such as weight lifting or push-up exercises are not recommended after early discharge. The exercise intensity can be increased after 3 months of AMI or surgery according to the presence of symptoms. Before and after the exercise, the warm-up and cooling periods should be 5–10 min. In this period, it is recommended to avoid competing sports [31]. An outpatient program should be 2–6 months’ duration [77, 78]. Home-based rehabilitation is like centre-based cardiac rehabilitation in terms of the mortality of the patients with a low risk after AMI or revascularization [77].
7.3 The Selection of Exercise Program
In the selection of exercise, the risk classification of the CAD patients should be taken into consideration (Table 11.3). In general, the dynamic exercises, in which large muscle groups participate, are well tolerated by patients with CAD. The CAD patients’ clinical condition, exercise tolerance, interest, and ability are the important variables influencing the selection of the exercise type. In the period after AMI or revascularization, bicycle ergometer or treadmill can be used. When planning an exercise prescription, it is very important to calculate the appropriate exercise intensity for each patient. Exercise should be intense enough to be beneficial for health fitness and performance, but this intensity should not lead to fatigue or cardiovascular symptoms, such as angina pectoris or dyspnea. The intensity, frequency, and duration of the exercise should be planned appropriately [31]. Heart rate and energy expenditure are directly proportional and very useful in determining the intensity of exercise for CAD patients. The prediction of energy expenditure from heart rate during exercise is possible [79]. Target heart rate during exercise is generally can be calculated with the formula (220 − age), and the target exercise heart rate of 50–80% is an optimal range [80]. The exercise test can be used to determine the appropriate heart rate. For example, if the symptoms of a patient begin at 130 beats/min, the safe interval is less than 130 beats/min. In this case, exercise should be done below the heart rate of 110 beats/min. This heart rate can be increased up to 10% per week according to the presence of symptoms. In patients with low exercise capacity (<5 MET), the exercise should be started with a target exercise heart rate of 40–50%, and the walking will be most useful for the exercise choice. Aerobic and dynamic exercise training sessions should be performed at least 3 days a week, and 250–300 kcal should be spent in one session. The weekly exercise frequency should be increased as much as possible. Approximately 1600 kcal of weekly energy expenditure with a moderate intensity exercise provides significant benefit in patients with CAD [81]. Exercise should not be done more than 5 days per week, which may increase orthopedic problems [31].
8 Exercise and CAD Patients According to Guidelines
Exercise programs are important for the prevention and treatment of CAD patients, and the American Heart Association, the American College of Cardiology, and the European Society of Cardiology give a Class I recommendation as a fundamental therapy [82,83,84]. CAD patients may present their heart disease as asymptomatic (silent ischemia) or symptomatic. However, asymptomatic patients can be documented after exercise testing, stress nuclear imaging, or echocardiography. If necessary, the coronary artery anatomy is evaluated with computerized angiography and calcium score and imaging or coronary angiography in both groups’ patients. Stenosis greater than 50% is considered significant. Maximal exercise test is taken under medical treatment in order to determine if there is exercise tolerance, electrical instability, and inducible ischemia in patients with known CAD. Echocardiography should also be performed for the evaluation of left ventricle functions. Patients with CAD should strongly consider deferring their possible return to highly intensive exercise to permit lesion regression and regression of lipid from the plaque. In these patients, statin therapy should be performed well according to guidelines for at least 2 years to reduce the risk of plaque rupture (Class 1; Level of evidence A). CAD patients should undergo an evaluation of left ventricular function (Class I; Level of evidence C). Asymptomatic CAD patients with the left ventricle resting ejection fraction (%) (EF) value of >50% and coronary artery stenosis of less than 50% can do competitive sports or intensive exercises if they are electrically stable during exercise and/or with induced ischemia by exercise (Class IIb; Level of evidence C). Patients should be given detailed information on the sudden outbreak or change of symptoms and should be checked regularly. According to the workforce (MET value) obtained in the exercise test and their clinical features, patients with electrically unstable or EF value <50% during the exercise test can do their exercise programs with 1A (bowling, cricket, curling, golf, riflery, yoga) and 1B (baseball, softball, fencing, table tennis, volleyball) (Class IIB, Evidence level C) sports or at low intensity (20–40% of VO2 peak). If the patient with symptomatic CAD has undergone a revascularization procedure or has had an acute coronary event, he/she should stay away from any competitive sport within the next 3 months (Class IIb; Level of evidence C). If the duration and frequency of their symptoms increase, their exercise programs should never be competitive (Class IIb; Evidence Level C). Those who have coronary artery spasm and who do not have significant CAD disease can participate in competitive sports or higher-intensity exercise if complete relief is provided by medical treatment, but this indication is weak according to new clinical studies (Class IIb; Level of evidence C). Sports activities should be kept at 1A–B or 2A–B level according to their clinical features in patients with a history of spontaneous coronary dissection [26]. CAD patients with complete revascularization and without ischemia or myocardial depression can do competitive sports or do exercise at higher intensity according to their symptom threshold.
References
Wilson PW (1994) Established risk factors and coronary artery disease: the Framingham study. Am J Hypertens 7(7 Pt 2):7s–12s
Warren TY, Barry V, Hooker SP, Sui X, Church TS, Blair SN (2010) Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc 42(5):879
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J (2010) Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 121(7):948–954
Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111(2):383–390
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN (2002) ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 40(7):1366–1374
Rahimtoola SH (1995) From coronary artery disease to heart failure: role of the hibernating myocardium. Am J Cardiol 75(13):E16–E22
Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32(9):2045–2051
Libby P, Ridker PM, Hansson GK (2009) Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54(23):2129–2138
Colbert LH, Visser M, Simonsick EM, Tracy RP, Newman AB, Kritchevsky SB, Pahor M, Taaffe DR, Brach J, Rubin S, Harris TB (2004) Physical activity, exercise, and inflammatory markers in older adults: findings from the health, aging and body composition study. J Am Geriatr Soc 52(7):1098–1104
Koenig W, Ernst E (2000) Exercise and thrombosis. Coron Artery Dis 11(2):123–127
Linke A, Schoene N, Gielen S, Hofer J, Erbs S, Schuler G, Hambrecht R (2001) Endothelial dysfunction in patients with chronic heart failure: systemic effects of lower-limb exercise training. J Am Coll Cardiol 3(2):392–397
Austin MA, King M-C, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82(2):495–506
Wood D (2001) Established and emerging cardiovascular risk factors. Am Heart J 141(2):S49–S57
Franco OH, de Laet C, Peeters A, Jonker J, Mackenbach J, Nusselder W (2005) Effects of physical activity on life expectancy with cardiovascular disease. Arch Intern Med 165(20):2355–2360
Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN (2000) ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 102(10):1193–1209
Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B (2002) Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 105(18):2143–2147
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206–1252
Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V (1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 34(4):1348–1359
Committee G (2003) 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21(6):1011–1053
Thompson PD, Buchner D, Piña IL, Balady GJ, Williams MA, Marcus BH, Berra K, Blair SN, Costa F, Franklin B (2003) Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107(24):3109–3116
Arena R, Myers J, Williams MA, Gulati M, Kligfield P, Balady GJ, Collins E, Fletcher G (2007) Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 116(3):329–343
Gielen S, Schuler G, Hambrecht R (2001) Exercise training in coronary artery disease and coronary vasomotion. Circulation 103(1):e1–e6
Ribeiro F, Alves AJ, Duarte JA, Oliveira J (2010) Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int J Cardiol 141(3):214–221
Luk T-H, Dai Y-L, Siu C-W, Yiu K-H, Chan H-T, Lee SW, Li S-W, Fong B, Wong W-K, Tam S (2012) Effect of exercise training on vascular endothelial function in patients with stable coronary artery disease: a randomized controlled trial. Eur J Prev Cardiol 19(4):830–839
Walther C, Möbius-Winkler S, Linke A, Bruegel M, Thiery J, Schuler G, Halbrecht R (2008) Regular exercise training compared with percutaneous intervention leads to a reduction of inflammatory markers and cardiovascular events in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 15(1):107–112
Maron BJ, Zipes DP, Kovacs RJ (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. Circulation 132(22):e256–e261
Maron BJ, Zipes DP, Kovacs RJ (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 66(21):2343–2349
Clausen JP (1976) Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease. Prog Cardiovasc Dis 18(6):459–495
Hirzel HO, Leutwyler R, Krayenbuehl HP (1985) Silent myocardial ischemia: hemodynamic changes during dynamic exercise in patients with proven coronary artery disease despite absence of angina pectoris. J Am Coll Cardiol 6(2):275–284
Bertagnoli K, Hanson P, Ward A (1990) Attenuation of exercise-induced ST depression during combined isometric and dynamic exercise in coronary artery disease. Am J Cardiol 65(5):314–317
Tolga S (2016) Coronary heart disease and exercise. Turk J Sports Med 51(2):056–068
Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R, Simons-Morton DA, Williams MA, Bazzarre T (2001) Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104(14):1694–1740
Clausen JP, Trap-Jensen J (1976) Heart rate and arterial blood pressure during exercise in patients with angina pectoris. Effects of training and of nitroglycerin. Circulation 53(3):436–442
Thadani U, West RO, Mathew TM, Parker JO (1977) Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease. Am J Cardiol 39(6):776–783
Sanchez J, Monod H, Chabaud F (1979) Effects of dynamic, static and combined work on heart rate and oxygen consumption. Ergonomics 22(8):935–943
Swirski FK, Nahrendorf M (2013) Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339(6116):161–166
Hansson GK, Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6(7):508
Palmefors H, DuttaRoy S, Rundqvist B, Börjesson M (2014) The effect of physical activity or exercise on key biomarkers in atherosclerosis—a systematic review. Atherosclerosis 235(1):150–161
Goldhammer E, Tanchilevitch A, Maor I, Beniamini Y, Rosenschein U, Sagiv M (2005) Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 100(1):93–99
Niessner A, Richter B, Penka M, Steiner S, Strasser B, Ziegler S, Heeb-Elze E, Zorn G, Leitner-Heinschink A, Niessner C (2006) Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization? Atherosclerosis 186(1):160–165
Marumoto K, Hamada M, Hiwada K (1995) Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci 88(5):551–556
Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA (2007) N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 297(2):169–176
Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R (2005) N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352(7):666–675
Foote RS, Pearlman JD, Siegel AH, Yeo KT (2004) Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44(10):1980–1987
Scardovi AB, De Maria R, Colettat C, Aspromonte N, Perna S, Infusino T, D’Errigo P, Rosato S, Greggi M, Di Giacomo T, Riccio R, Cec V (2006) Brain natriuretic peptide is a reliable indicator of ventilatory abnormalities during cardiopulmonary exercise test in heart failure patients. Med Sci Monit 12(5):Cr191–Cr195
Lavie CJ, Milani RV (2011) Cardiac rehabilitation and exercise training in secondary coronary heart disease prevention. Prog Cardiovasc Dis 53(6):397–403
Milani RV, Lavie CJ, Spiva H (1995) Limitations of estimating metabolic equivalents in exercise assessment in patients with coronary artery disease. Am J Cardiol 75(14):940–942
Lavie CJ, Milani RV (2000) Disparate effects of improving aerobic exercise capacity and quality of life after cardiac rehabilitation in young and elderly coronary patients. J Cardiopulm Rehabil Prev 20(4):235–240
Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ (2003) Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 42(12):2139–2143
Vanhees L, Fagard R, Thijs L, Amery A (1995) Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery. Am J Cardiol 76(14):1014–1019
Milani RV, Lavie CJ (1995) Prevalence and effects of nonpharmacologic treatment of “isolated” low-HDL cholesterol in patients with coronary artery disease. J Cardpulm Rehabil 15(6):439–444
Lavie CJ, Milani RV (1994) Effects of cardiac rehabilitation and exercise training on low-density lipoprotein cholesterol in patients with hypertriglyceridemia and coronary artery disease. Am J Cardiol 74(12):1192–1195
Lavie CJ, Milani RV (1996) Effects of nonpharmacologic therapy with cardiac rehabilitation and exercise training in patients with low levels of high-density lipoprotein cholesterol. Am J Cardiol 78(11):1286–1289
Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Thomas RJ, Squires RW, Allison TG (2008) Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil 15(3):336–340
Lavie CJ, Milani RV (1997) Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients. Am J Cardiol 79(4):397–401
Milani RV, Lavie CJ (2003) Prevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitation. Am J Cardiol 92(1A):50–50
Lavie CJ, Morshedi-Meibodi A, Milani RV (2008) Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients. J Cardiometab Syndr 3(3):136–140
Caulin-Glaser T, Falko J, Hindman L, La Londe M, Snow R (2005) Cardiac rehabilitation is associated with an improvement in C-reactive protein levels in both men and women with cardiovascular disease. J Cardiopulm Rehabil Prev 25(6):332–336
Lavie CJ, Milani RV, O’Keefe JH, Lavie TJ (2011) Impact of exercise training on psychological risk factors. Prog Cardiovasc Dis 53(6):464–470
Artham SM, Lavie CJ, Milani RV (2008) Cardiac rehabilitation programs markedly improve high-risk profiles in coronary patients with high psychological distress. South Med J 101(3):262–267
Lucini D, Milani RV, Costantino G, Lavie CJ, Porta A, Pagani M (2002) Effects of cardiac rehabilitation and exercise training on autonomic regulation in patients with coronary artery disease. Am Heart J 143(6):977–983
O’Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS Jr, Hennekens CH (1989) An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 80(2):234–244
Goel K, Lennon RJ, Tilbury RT, Squires RW, Thomas RJ (2011) Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 123(21):2344–2352
Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS (2016) Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 67(1):1–12
Mezzani A, Hamm LF, Jones AM, McBride PE, Moholdt T, Stone JA, Urhausen A, Williams MA (2013) Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol 20(3):442–467
Vanhees L, Stevens A, Schepers D, Defoor J, Rademakers F, Fagard R (2004) Determinants of the effects of physical training and of the complications requiring resuscitation during exercise in patients with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 11(4):304–312
Pattyn N, Beulque R, Cornelissen V (2018) Aerobic interval vs. continuous training in patients with coronary artery disease or heart failure: an updated systematic review and meta-analysis with a focus on secondary outcomes. Sports Med (Auckland, NZ) 48(5):1189–1205
Moholdt T, Madssen E, Rognmo O, Aamot IL (2014) The higher the better? Interval training intensity in coronary heart disease. J Sci Med Sport 17(5):506–510
Kodama S, Saito K, Tanaka S, Maki M, Yachi Y, Asumi M, Sugawara A, Totsuka K, Shimano H, Ohashi Y, Yamada N, Sone H (2009) Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 301(19):2024–2035
Villelabeitia Jaureguizar K, Vicente-Campos D, Ruiz Bautista L, Hernández de la Peña C, Gómez A, José M, Calero Rueda MJ, Fernández Mahillo I (2016) Effect of high-intensity interval versus continuous exercise training on functional capacity and quality of life in patients with coronary artery disease. J Cardiopulm Rehabil Prev 36(2):96–105
Lavie CJ, Thomas RJ, Squires RW, Allison TG, Milani RV (2009) Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc 4:373–383
Swift DL, Lavie CJ, Johannsen NM, Arena R, Earnest CP, O’Keefe JH, Milani RV, Blair SN, Church TS (2013) Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J 77(2):281–292
Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP (2011) American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 43(7):1334–1359
Huang K, Liu W, He D, Huang B, Xiao D, Peng Y, He Y, Hu H, Chen M, Huang D (2015) Telehealth interventions versus center-based cardiac rehabilitation of coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol 22(8):959–971
Jin K, Khonsari S, Gallagher R, Gallagher P, Clark AM, Freedman B, Briffa T, Bauman A, Redfern J, Neubeck L (2019) Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review and meta-analysis. Eur J Cardiovasc Nurs. https://doi.org/10.1177/1474515119826510
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119–177
Dalal HM, Zawada A, Jolly K, Moxham T, Taylor RS (2010) Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ 340:b5631
Corra U, Piepoli MF, Carre F, Heuschmann P, Hoffmann U, Verschuren M, Halcox J, Giannuzzi P, Saner H, Wood D, Piepoli MF, Corra U, Benzer W, Bjarnason-Wehrens B, Dendale P, Gaita D, McGee H, Mendes M, Niebauer J, Zwisler AD, Schmid JP (2010) Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur Heart J 31(16):1967–1974
Keytel L, Goedecke J, Noakes T, Hiiloskorpi H, Laukkanen R, van der Merwe L, Lambert E (2005) Prediction of energy expenditure from heart rate monitoring during submaximal exercise. J Sports Sci 23(3):289–297
Blanchard CM, Rodgers WM, Spence JC, Courneya KS (2001) Feeling state responses to acute exercise of high and low intensity. J Sci Med Sport 4(1):30–38
Leon AS (1985) Physical activity levels and coronary heart disease: analysis of epidemiologic and supporting studies. Med Clin N Am 69(1):3–20
Balady GJ, Ades PA, Bittner VA, Franklin BA, Gordon NF, Thomas RJ, Tomaselli GF, Yancy CW (2011) Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation 124(25):2951–2960
Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, Gibbons RJ, Grundy SM, Hiratzka LF, Jones DW, Lloyd-Jones DM, Minissian M, Mosca L, Peterson ED, Sacco RL, Spertus J, Stein JH, Taubert KA (2011) AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 58(23):2432–2446
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F (2013) [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)]. G Ital Cardiol (2013) 14(5):328–392
Competing Financial Interests
The author declares no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Akyuz, A. (2020). Exercise and Coronary Heart Disease. In: Xiao, J. (eds) Physical Exercise for Human Health. Advances in Experimental Medicine and Biology, vol 1228. Springer, Singapore. https://doi.org/10.1007/978-981-15-1792-1_11
Download citation
DOI: https://doi.org/10.1007/978-981-15-1792-1_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-1791-4
Online ISBN: 978-981-15-1792-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)